APA

Kodama H., Suzuki M., Katayose Y., Shinoda M., Sakurai N., Takemura S., Yoshida H., Saeki H., Asano R., Ichiyama M., Imai K., Hinoda Y., Matsuno S. & Kudo T. (20020731). Specific and effective targeting cancer immunotherapy with a combination of three bispecific antibodies. : Immunology letters.

Chicago

Kodama Hideaki, Suzuki Masanori, Katayose Yu, Shinoda Masao, Sakurai Naoki, Takemura Shin-ichi, Yoshida Hiroshi, Saeki Hisaaki, Asano Ryutaro, Ichiyama Masahiko, Imai Kohzoh, Hinoda Yuji, Matsuno Seiki and Kudo Toshio. 20020731. Specific and effective targeting cancer immunotherapy with a combination of three bispecific antibodies. : Immunology letters.

Harvard

Kodama H., Suzuki M., Katayose Y., Shinoda M., Sakurai N., Takemura S., Yoshida H., Saeki H., Asano R., Ichiyama M., Imai K., Hinoda Y., Matsuno S. and Kudo T. (20020731). Specific and effective targeting cancer immunotherapy with a combination of three bispecific antibodies. : Immunology letters.

MLA

Kodama Hideaki, Suzuki Masanori, Katayose Yu, Shinoda Masao, Sakurai Naoki, Takemura Shin-ichi, Yoshida Hiroshi, Saeki Hisaaki, Asano Ryutaro, Ichiyama Masahiko, Imai Kohzoh, Hinoda Yuji, Matsuno Seiki and Kudo Toshio. Specific and effective targeting cancer immunotherapy with a combination of three bispecific antibodies. : Immunology letters. 20020731.